Seres Therapeutics Inc MCRB:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
1.15quote price arrow down-0.01 (-0.86%)
Volume
48,111
Close
1.16quote price arrow up+0.05 (+4.50%)
Volume
4,378,804
52 week range
0.54 - 6.26
Loading...
  • Open1.11
  • Day High1.19
  • Day Low1.08
  • Prev Close1.11
  • 52 Week High6.26
  • 52 Week High Date06/14/23
  • 52 Week Low0.54
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap175.171M
  • Shares Out151.01M
  • 10 Day Average Volume6.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.96
  • YTD % Change-17.14

KEY STATS

  • Open1.11
  • Day High1.19
  • Day Low1.08
  • Prev Close1.11
  • 52 Week High6.26
  • 52 Week High Date06/14/23
  • 52 Week Low0.54
  • 52 Week Low Date04/19/24
  • Market Cap175.171M
  • Shares Out151.01M
  • 10 Day Average Volume6.21M
  • Dividend-
  • Dividend Yield-
  • Beta1.96
  • YTD % Change-17.14

RATIOS/PROFITABILITY

  • EPS (TTM)-0.90
  • P/E (TTM)-1.29
  • Fwd P/E (NTM)-0.97
  • EBITDA (TTM)-101.74M
  • ROE (TTM)-538.57%
  • Revenue (TTM)126.325M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-90.02%
  • Debt To Equity (MRQ)-226.38%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seres Therapeutics Inc

 

Profile

MORE
Seres Therapeutics, Inc. is a commercial-stage microbiome therapeutics company. It is focused on the development and commercialization of a novel class of biological drugs, which are designed to treat disease by modulating the microbiome to restore health by repairing the function of a disrupted microbiome to a non-disease state. Its lead program, VOWST, is to prevent recurrence of Clostridioides difficile infection (CDI) in patients 18 or older following antibacterial...
Stephen Berenson
Independent Chairman of the Board
Eric Shaff
President, Chief Executive Officer, Director
Marella Thorell
Chief Financial Officer, Executive Vice President
Matthew Henn Ph.D.
Executive Vice President, Chief Scientific Officer
Lisa von Moltke M.D.
Executive Vice President, Chief Medical Officer
Address
101 Cambridge Park Drive
Cambridge, MA
02140
United States

Top Peers

SYMBOLLASTCHG%CHG
PRAX
Praxis Precision Medicines Inc
54.54+0.38+0.70%
VXRT
Vaxart Inc
0.7289-0.0201-2.6836%
PRQR
ProQR Therapeutics NV
2.01+0.02+1.01%
OBIO
Orchestra Biomed Holdings Inc
5.10-0.45-8.11%
SYRS
Syros Pharmaceuticals Inc
5.13-0.07-1.35%